1. Kaszicki J, Sliwinsksa A, and Drzewoski J. Metformin in cancer prevention and therapy. Annals of Translational Medicine. Juni 2014; 2 (6): p.57. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200668/
2. Ballotari P, Vicentini M, Manicardi V, et al. Diabetes and risk of cancer incidence: results from a population-based cohort study in northern Italy. BMC Cancer, 2017. 17(1). doi:10.1186/s12885-017-3696-4
3. Zi F, Zi H, et al. Metformin and cancer : An existing drug for cancer prevention and therapy. Oncology Letters. November 2017; 15 (1): p. 683-90. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772929/
4. Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and Cancer: A Consensus Report. CA: A Cancer Journal for Clinicians, 2010. 60(4): 207–221. doi:10.3322/caac.20078
5. Giovannuci E, Harlan DM, et al. Diabetes and cancer A consensus report. Diabetes care. Juli 2010; 33 (7): p. 1674-85. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890380/
6. Brandy M, Heckman S, et al. Repurposing metformin for the prevention of cancer and cancer recurrence. Diabetologia. Agustus 2017; 60: p. 1639-47. https://link.springer.com/content/pdf/10.1007%2Fs00125-017-4372-6.pdf
7. Coyle C, Cafferty FH, et al. Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis. Annals of oncology. Desember 2016; 27 (12): p. 2184-95. https://academic.oup.com/annonc/article/27/12/2184/2736338
8. Griss T, Vincent EE, Egnatchik R, et al. Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis. PLOS Biology, 2015. 13(12): e1002309. doi:10.1371/journal.pbio.1002309
9. Xiao K, Liu F, Liu J, et al. The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta-analysis. J Clin Pharm Ther. 2020;45(4):783-792.
10. Zhang K, Bai P, Dai H. Metformin and risk of cancer among patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Primary Care Diabetes. 2021; 15(1):52-58.
11. Kordes S, Pollak MN, Zwinderman AH, et al. Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial. The Lancet Oncology, 2015. 16(7): 839–847.doi:10.1016/s1470-2045(15)00027-3 \
12. Rêgo DF, Pavan LMC, Elias ST, et al. Effects of metformin on head and neck cancer: A systematic review. Oral Oncology, 2015. 51(5): 416–422. doi:10.1016/j.oraloncology.2015.01.007
13. Xie W, Li T, Yang J, et al. Metformin use and survival outcomes in endometrial cancer, a systematic review and metaanalysis. Oncotarget, 2017. https://doi.org/10.18632/oncotarget.20388